Meet Sara Revolinski, PharmD, BCPS

"I strongly believe education and life-long learning is at the core of successful pharmacy practice. Beyond teaching foundational knowledge, I also focus on promoting open communication, critical thinking and reasoning, and engaging learners to take ownership of education. I believe teaching these skills will develop pharmacy practitioners who are well positioned to positively impact the health of our community throughout their careers."

Sara Revolinski, PharmD, BCPS

Sara Revolinksi, PharmD, BCPS

Clinical Assistant Professor
Department of Clinical Sciences





Sara Revolinski, PharmD, BCPS joined the MCW School of Pharmacy in September 2016 as a Clinical Assistant Professor. Dr. Revolinski is the Antimicrobial Stewardship Coordinator for the Froedtert and Medical College of Wisconsin health system, a role she has held since April of 2013. Dr. Revolinski earned her Doctor of Pharmacy degree in 2006 from the University Of Wisconsin. Following graduation, she completed her postgraduate-year-1 residency training at Froedtert and the Medical College of Wisconsin. Dr. Revolinski spent several years working as a clinical pharmacist at ThedaCare, where she worked jointly with an infectious diseases provider to develop an antimicrobial stewardship program. In 2012, she rejoined the pharmacy staff at Froedtert and the Medical College of Wisconsin. Additionally, Dr. Revolinski holds an Antimicrobial Stewardship Certificate from the Society of Infectious Diseases Pharmacists and is a board certified pharmacotherapy specialist. 

Open AllClose All
  Education and Training

Doctor of Pharmacy (PharmD) - University of Wisconsin School of Pharmacy


Post Graduate Year One (PGY1) Pharmacy Practice Residency - Froedtert Hospital






Board Certified Pharmacotherapy Specialist (BCPS) - Board of Pharmacy Specialties


Antimicrobial Stewardship Certificate - Society of Infectious Diseases Pharmacists


Registered Pharmacist - State of Wisconsin

  Research Interests
  • Antimicrobial stewardship outcomes research
  • Rapid diagnostic technology and its impact on antimicrobial stewardship
  • Pharmacokinetics and pharmacodynamics of antimicrobial agents
  • Clostridium difficile and other multidrug-resistant infections